Cargando…

Features of Inflammatory Heart Reactions Following mRNA COVID‐19 Vaccination at a Global Level

Myocarditis and pericarditis may constitute adverse reactions of mRNA coronavirus disease 2019 (COVID‐19) vaccines. This study aimed to document these reactions and to assess the association with patient sex and age. This is as an observational retrospective study using a case–non‐case design (also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chouchana, Laurent, Blet, Alice, Al‐Khalaf, Mohammad, Kafil, Tahir S., Nair, Girish, Robblee, James, Drici, Milou‐Daniel, Valnet‐Rabier, Marie‐Blanche, Micallef, Joëlle, Salvo, Francesco, Treluyer, Jean‐Marc, Liu, Peter P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015432/ https://www.ncbi.nlm.nih.gov/pubmed/34860360 http://dx.doi.org/10.1002/cpt.2499

Ejemplares similares

Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
por: Salvo, Francesco, et al.
Publicado: (2023)

Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
por: Valnet-Rabier, Marie-Blanche, et al.
Publicado: (2023)

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2023)

COVID-19 vaccines surveillance in France: a global response to a major national challenge
por: Benkebil, Mehdi, et al.
Publicado: (2021)

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021)

“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
por: Gérard, Alexandre, et al.
Publicado: (2020)

Acute Pancreatitis Occurring after Pamidronate Infusions in Two Patients with Spondyloarthritis
por: Toussirot, Éric, et al.
Publicado: (2013)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet
por: Azar, Christine, et al.
Publicado: (2021)

Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT)
por: Laroche, Marie‐Laure, et al.
Publicado: (2022)

Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case–noncase study
por: Chouchana, Laurent, et al.
Publicado: (2021)

Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic
por: Romani, Serena, et al.
Publicado: (2020)

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
por: Moulis, Guillaume, et al.
Publicado: (2022)

Risque de vascularites systémiques après une vaccination anti-SARS-CoV-2 à base d’ARN : une étude de pharmacovigilance
por: Mettler, C., et al.
Publicado: (2022)

Safety of Omalizumab During Pregnancy and Breast-Feeding With Assessment of Placental Transfer: A Case Report
por: Majou, Doriane, et al.
Publicado: (2020)

Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers
por: Chouchana, Laurent, et al.
Publicado: (2022)

Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
por: Soeiro, Thomas, et al.
Publicado: (2021)

Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis()
por: Murarasu, Anne, et al.
Publicado: (2023)

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease
por: Turco, Célia, et al.
Publicado: (2015)

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres
por: Gras-Champel, Valérie, et al.
Publicado: (2021)

Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination: Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database
por: Thai-Van, Hung, et al.
Publicado: (2023)

Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
por: Chouchana, Laurent, et al.
Publicado: (2021)

Correction to: Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19
por: Chouchana, Laurent, et al.
Publicado: (2021)

Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
por: Schweitzer-Chaput, Arnaud, et al.
Publicado: (2023)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
por: Merino, Diane, et al.
Publicado: (2022)

Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic
por: Lory, Pauline, et al.
Publicado: (2022)

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Jouanjus, Emilie, et al.
Publicado: (2019)

Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
por: Martin, Guillaume L., et al.
Publicado: (2022)

Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
por: Létinier, Louis, et al.
Publicado: (2021)

COVID-19 Vaccine-Associated Transient Global Amnesia: A Disproportionality Analysis of the WHO Safety Database
por: Merino, Diane, et al.
Publicado: (2022)

Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine
por: Robblee, Jennifer
Publicado: (2023)

Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
por: Funck-Brentano, Christian, et al.
Publicado: (2020)

Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis
por: Merino, Diane, et al.
Publicado: (2022)

Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?
por: Gérard, Alexandre O., et al.
Publicado: (2022)

Are current guidelines adapted for patient eligibility to PrEP? A case report
por: Van Obberghen, Elise K., et al.
Publicado: (2019)

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
por: Létinier, Louis, et al.
Publicado: (2021)

Distinguishing Radiculopathies from Mononeuropathies
por: Robblee, Jennifer, et al.
Publicado: (2016)

Myocarditis in 2020: Advancements in Imaging and Clinical Management
por: Kafil, Tahir S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h838jm3pjocp22ak9d1jdo15vf